Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jian Gao, Zhaojun Duan, Ling Zhang, Xiangbo Huang, Lu Long, Jing Tu, Hua Liang, Yu Zhang, Tao Shen & Fengmin Lu. (2016) Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. OncoImmunology 5:1.
Read now
Read now
Panagiotis Tsirigotis, Avichai Shimoni & Arnon Nagler. (2014) The expanding horizon of immunotherapy in the treatment of malignant disorders: Allogeneic hematopoietic stem cell transplantation and beyond. Annals of Medicine 46:6, pages 384-396.
Read now
Read now
Assaf Marcus & Zelig Eshhar. (2014) Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opinion on Biological Therapy 14:7, pages 947-954.
Read now
Read now
Elisabetta Cariani & Gabriele Missale. (2013) KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma. OncoImmunology 2:12.
Read now
Read now
Articles from other publishers (18)
Hee Young Kang, Soo Yun Lee, Hyun Min Kim, Su Ui Lee, Hyunseung Lee, Mi Young Cho, Se-Chan Oh, Seok-Min Kim, Hye Sun Park, Eun Hee Han, Seong-Eun Kim, Hyori Kim, Suk Ran Yoon, Junsang Doh, Junho Chung, Kwan Soo Hong, Inpyo Choi & Tae-Don Kim. (2023) A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets. Frontiers in Immunology 13.
Crossref
Crossref
Karol Sadowski, Wioletta Olejarz & Grzegorz Basak. (2022) Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment. International Journal of Molecular Sciences 23:23, pages 15006.
Crossref
Crossref
Dayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, Graziela de Moura Aguiar, Mariane Cariati Tirapelle, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Dimas Tadeu Covas & Virginia Picanço-Castro. (2022) Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy. Immunotherapy Advances 2:1.
Crossref
Crossref
Faroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Thangavelu, Aleksey Dorofeev, Favian Bayas-Morejón, Naghmeh Shirafkan, Navid Shomali, Max Stanley Chartrand, Mostafa Jarahian, Ghasem Vahedi, Rebar N. Mohammed, Somayeh Shahrokh, Morteza Akbari & Farhad Motavalli Khiavi. (2021) Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Pranav Oberoi, Kathrina Kamenjarin, Jose Francisco Villena Ossa, Barbara Uherek, Halvard Bönig & Winfried S. Wels. (2020) Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity. Cells 9:4, pages 811.
Crossref
Crossref
Laura Sanz-Ortega, José M. Rojas, Yadileiny Portilla, Sonia Pérez-Yagüe & Domingo F. Barber. (2019) Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Frontiers in Immunology 10.
Crossref
Crossref
Ping Zhang, Songbo Zhao, Chao Wu, Jialu Li, Zixuan Li, Chunmei Wen, Siyi Hu, Gangli An, Huimin Meng, Xingding Zhang & Lin Yang. (2018) Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages. Immunotherapy 10:11, pages 935-949.
Crossref
Crossref
Huimin Meng, Xue Sun, Yanhui Song, Jianxuan Zou, Gangli An, Zeming Jin & Lin Yang. (2018) La/SSB chimeric autoantibody receptor modified NK92MI cells for targeted therapy of autoimmune disease. Clinical Immunology 192, pages 40-49.
Crossref
Crossref
Lucía Fernández, Jean-Yves Metais, Adela Escudero, María Vela, Jaime Valentín, Isabel Vallcorba, Alejandra Leivas, Juan Torres, Antonio Valeri, Ana Patiño-García, Joaquín Martínez, Wing Leung & Antonio Pérez-Martínez. (2017) Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Clinical Cancer Research 23:19, pages 5824-5835.
Crossref
Crossref
Ying Chen, Fengtao You, Licui Jiang, Jialu Li, Xuejun Zhu, Yangyi Bao, Xiang Sun, Xiaowen Tang, Huimin Meng, Gangli An, Bozhen Zhang & Lin Yang. (2017) Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody. Oncotarget 8:23, pages 37128-37139.
Crossref
Crossref
Fang Fang, Weihua Xiao & Zhigang Tian. (2017) NK cell-based immunotherapy for cancer. Seminars in Immunology 31, pages 37-54.
Crossref
Crossref
Congcong Zhang, Pranav Oberoi, Sarah Oelsner, Anja Waldmann, Aline Lindner, Torsten Tonn & Winfried S. Wels. (2017) Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity. Frontiers in Immunology 8.
Crossref
Crossref
Ho-Young Park, Taek Joon Yoon, Wookyung Lee, Yoonsook Kim & Hee-Don Choi. (2017) Antimetastatic effect of glycoprotein isolated from rice bran on colon 26-M3.1 cell line. Journal of Functional Foods 32, pages 278-284.
Crossref
Crossref
Gabriella Pietra, Chiara Vitale, Daniela Pende, Alice Bertaina, Francesca Moretta, Michela Falco, Paola Vacca, Elisa Montaldo, Claudia Cantoni, Maria Cristina Mingari, Alessandro Moretta, Franco Locatelli & Lorenzo Moretta. (2015) Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias. Cancer Immunology, Immunotherapy 65:4, pages 465-476.
Crossref
Crossref
Fan Yang, Hao Jin, Jian Wang, Qian Sun, Cihui Yan, Feng Wei & Xiubao Ren. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
169
239
.
Claudia Cantoni, Korneel Grauwet, Gabriella Pietra, Monica Parodi, Maria Cristina Mingari, Andrea De Maria, Herman Favoreel & Massimo Vitale. (2015) Role of NK cells in immunotherapy and virotherapy of solid tumors. Immunotherapy 7:8, pages 861-882.
Crossref
Crossref
Kurt Schönfeld, Christiane Sahm, Congcong Zhang, Sonja Naundorf, Christian Brendel, Marcus Odendahl, Paulina Nowakowska, Halvard Bönig, Ulrike Köhl, Stephan Kloess, Sylvia Köhler, Heidi Holtgreve-Grez, Anna Jauch, Manfred Schmidt, Ralf Schubert, Klaus Kühlcke, Erhard Seifried, Hans G Klingemann, Michael A Rieger, Torsten Tonn, Manuel Grez & Winfried S Wels. (2015) Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor. Molecular Therapy 23:2, pages 330-338.
Crossref
Crossref
Cristina Eguizabal, Olatz Zenarruzabeitia, Jorge Monge, Silvia Santos, Miguel Angel Vesga, Natalia Maruri, Arantza Arrieta, Marta Riñón, Estibaliz Tamayo-Orbegozo, Laura Amo, Susana Larrucea & Francisco Borrego. (2014) Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective. Frontiers in Immunology 5.
Crossref
Crossref